SEC EDGAR filings, ownership reports, and insider transactions for Decheng Capital China Life Sciences USD Fund III, L.P..
Recent SEC filings for Decheng Capital China Life Sciences USD Fund III, L.P. including 4, 3, SC 13D and more.
| Form type | Document | Filing | Description | Filing date | Reporting date | File number(s) |
|---|---|---|---|---|---|---|
| 4 | Open 4 document | View SEC filing for 4 | 20 Oct 2025 | 16 Oct 2025 | 001-38024 | |
| 4 | Open 4 document | View SEC filing for 4 | 15 Oct 2025 | 13 Oct 2025 | 001-38024 | |
| 4 | Open 4 document | View SEC filing for 4 | 10 Oct 2025 | 08 Oct 2025 | 001-38024 | |
| 4 | Open 4 document | View SEC filing for 4 | 07 Oct 2025 | 03 Oct 2025 | 001-38024 | |
| 4 | Open 4 document | View SEC filing for 4 | 02 Oct 2025 | 30 Sep 2025 | 001-38024 | |
| 4 | Open 4 document | View SEC filing for 4 | 29 Sep 2025 | 25 Sep 2025 | 001-38024 | |
| 4 | Open 4 document | View SEC filing for 4 | 24 Sep 2025 | 22 Sep 2025 | 001-38024 | |
| 4 | Open 4 document | View SEC filing for 4 | 19 Sep 2025 | 17 Sep 2025 | 001-38024 | |
| 4 | Open 4 document | View SEC filing for 4 | 16 Sep 2025 | 12 Sep 2025 | 001-38024 | |
| 4 | Open 4 document | View SEC filing for 4 | 11 Sep 2025 | 09 Sep 2025 | 001-38024 | |
| 4 | Open 4 document | View SEC filing for 4 | 08 Sep 2025 | 04 Sep 2025 | 001-38024 | |
| 4 | Open 4 document | View SEC filing for 4 | 03 Sep 2025 | 29 Aug 2025 | 001-38024 | |
| 4 | Open 4 document | View SEC filing for 4 | 28 Aug 2025 | 26 Aug 2025 | 001-38024 | |
| 4 | Open 4 document | View SEC filing for 4 | 25 Aug 2025 | 21 Aug 2025 | 001-38024 | |
| 4 | Open 4 document | View SEC filing for 4 | 20 Aug 2025 | 18 Aug 2025 | 001-38024 | |
| 4 | Open 4 document | View SEC filing for 4 | 15 Aug 2025 | 14 Aug 2025 | 001-38024 | |
| 4 | Open 4 document | View SEC filing for 4 | 11 Aug 2025 | 17 Jun 2025 | 001-38024 | |
| 3 | Open 3 document | View SEC filing for 3 | 11 Aug 2025 | 02 Jan 2025 | 001-38024 | |
| SC 13D | Open SC 13D document | View SEC filing for SC 13D | SC 13D | 10 Sep 2024 | ||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | SC 13D/A | 21 May 2024 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 | 20 May 2024 | 18 May 2024 | 001-37449 |
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | SC 13D/A | 30 Apr 2024 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 22 Jan 2024 | 18 Jan 2024 | 001-37449 |
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | SC 13D/A | 14 Nov 2023 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 27 Sep 2022 | 23 Sep 2022 | 001-37449 |
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | SC 13D/A | 27 Sep 2022 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 | 30 Sep 2021 | 28 Sep 2021 | 001-40824 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 | 23 Sep 2021 | 23 Sep 2021 | 001-40824 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 | 21 Sep 2021 | 17 Sep 2021 | 001-37449 |
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | SC 13D/A | 21 Sep 2021 | ||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | AMENDMENT TO FORM SC 13D | 08 Dec 2020 | ||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | SC 13D/A | 03 Aug 2020 | ||
| SC 13D | Open SC 13D document | View SEC filing for SC 13D | ACQUISITION OF BENEFICIAL OWNERSHIP | 27 Jul 2020 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SC 13G/A | 10 Feb 2020 | ||
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | SCHEDULE 13G | 23 Dec 2019 | ||
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | SC 13G | 02 Aug 2019 | ||
| SC 13D | Open SC 13D document | View SEC filing for SC 13D | SCHEDULE 13D | 24 Jan 2019 | ||
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 23 Jan 2019 | 18 Jan 2019 | 001-37449 |
| D | Open D document | View SEC filing for D | 30 Apr 2018 | 021-311280 |
Decheng Capital China Life Sciences USD Fund III, L.P. files with the SEC under CIK 0001736814. This page aggregates EDGAR filings and related ownership activity.